Levin S, Robinson A, Zakut H
Padiatr Padol. 1986;21(3):233-9.
The Development Quotient (D.Q.) was tested in 48 full term infants at the ages of 12-24 months who had been treated antenatally with Betamethasone to hasten pulmonary maturity. The results were compared with a control group of 100 normal full term infants of the same age. Although the two groups differed with respect to gestational age, there were no differences in birth weight, Apgar score and method of delivery between them. The results of the D.Q. evaluation showed no significant difference between the two groups. The assumption is made, therefore, that antenatal treatment with Glucocorticosteroids in the second and third trimester does not adversely affect the infant's psychological and motor development.
对48名足月婴儿进行了发育商（D.Q.）测试，这些婴儿年龄在12至24个月，产前接受过倍他米松治疗以促进肺成熟。将结果与100名同龄正常足月婴儿的对照组进行比较。尽管两组在胎龄方面存在差异，但他们在出生体重、阿氏评分和分娩方式上没有差异。发育商评估结果显示两组之间没有显著差异。因此，可以假设在孕中期和孕晚期使用糖皮质激素进行产前治疗不会对婴儿的心理和运动发育产生不利影响。
